Clinical study of cefozopran for pneumonia
The clinical effects, safety and efficacy of cefozopran, a newly developed injectble cephalosporin, on pneumonia were investigated. The subjects were 6 inpatients with pneumonia, but one of them was excluded from the subjects, because the patient was clarified to have suffered pulmonary tuberuculosi...
Saved in:
| Published in: | CHEMOTHERAPY Vol. 41; no. Supplement4; pp. 566 - 569 |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Journal Article |
| Language: | English Japanese |
| Published: |
Japanese Society of Chemotherapy
1993
|
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | The clinical effects, safety and efficacy of cefozopran, a newly developed injectble cephalosporin, on pneumonia were investigated. The subjects were 6 inpatients with pneumonia, but one of them was excluded from the subjects, because the patient was clarified to have suffered pulmonary tuberuculosis during the treatment. All the 5 patients consisting of 4 men and 1 woman (ranging in age from 44 to 75 years) received intravenous cefozopran at a dose of 0.5-1.0g twice a day for 8-14 days. The drug was clinically effective in all patients. Pyogenic bacteria were identified in 4 patients, and they were eliminated. Although none of the patients had side effects, slight abnormalities in findigs of clinical tests observed in 2 patients. One of them had leukopenia and eosinophilia, and the other patient had leukopenia. There was no problem with the safety of this drug. |
|---|---|
| ISSN: | 0009-3165 1884-5894 |
| DOI: | 10.11250/chemotherapy1953.41.Supplement4_566 |